Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 7;13(41):5481-5.
doi: 10.3748/wjg.v13.i41.5481.

Clinical significance of activity of ALT enzyme in patients with hepatitis C virus

Onder Akkaya  1 , Murat Kiyici, Yusuf Yilmaz, Engin Ulukaya, Omer Yerci
Affiliations

Clinical significance of activity of ALT enzyme in patients with hepatitis C virus

Onder Akkaya et al. World J Gastroenterol. .

Abstract

Aim: To investigate serum alanine aminotransferase (ALT) levels in relation to the clinical, biochemical, ultrasonographic and histological characteristics of patients with hepatitis C virus.

Methods: Duration of disease, HCV-RNA, liver steatosis, and the hepatitis activity index (HAI) were correlated with serum ALT in 36 patients with HCV. ALT values were also investigated in 16 control subjects without any liver diseases.

Results: In bivariate analyses, ALT levels correlated with duration of HCV infection (P < 0.01), HCV-RNA (P < 0.05), and the HAI (P < 0.01). Among the components of the HAI, ALT concentrations were significantly associated with periportal bridging/necrosis (P < 0.01) and fibrosis (P < 0.05). In multivariate analysis, periportal bridging/necrosis (beta = 0.508; P < 0.01), duration of HCV infection (beta = 0.413; P < 0.01), and HCV-RNA (beta = 0.253; P < 0.05) were independently associated with ALT activity. The normal ALT activity for men and women was < 23 IU/L and < 22 IU/L, respectively.

Conclusion: In patients with HCV, alterations in the liver tissue as reflected by ALT elevation are mainly associated with periportal bridging/necrosis, viral load and duration of disease. A cut-off value < 23 IU/L distinguished with high diagnostic accuracy healthy controls from patients with HCV.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatter diagram and regression line showing a significant positive relationship between duration of HCV infection and serum alanine aminotransferase (r = 0.46, P < 0.01).
Figure 2
Figure 2
Scatter diagram and regression line showing a significant inverse relationship between viral load and serum alanine aminotransferase (r = -0.33, P < 0.05).
Figure 3
Figure 3
Scatter diagram and regression line showing a significant positive relationship between the Histology Activity Index and serum alanine aminotransferase (r = 0.44, P < 0.01).
Figure 4
Figure 4
ROC curve of serum ALT for discriminating female HCV patients from women without liver disease. The better cutoff value for ALT was at 22 IU/L, with sensitivity of 87.5% and specificity of 100% in identifying subjects without HCV infection.
Figure 5
Figure 5
ROC curve of serum ALT for discriminating male HCV patients from men without liver disease. The better cutoff value for ALT was at 23 IU/L, with sensitivity of 100% and specificity of 100% in identifying subjects without HCV infection.
See this image and copyright information in PMC

References

    1. Hughes CA, Shafran SD. Chronic hepatitis C virus management: 2000-2005 update. Ann Pharmacother. 2006;40:74–82. - PubMed
    1. Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol. 2007;13:2461–2466. - PMC - PubMed
    1. Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci. 2006;3:35–40. - PMC - PubMed
    1. Sievert W. Management issues in chronic viral hepatitis: hepatitis C. J Gastroenterol Hepatol. 2002;17:415–422. - PubMed
    1. Teoh NC, Farrell GC. Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J. 2004;34:324–337. - PubMed

MeSH terms